Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 6, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Type 1 Diabetes
Interventions
DEVICE

DreaMed Endo Digital

The DreaMed Endo.Digital uses information gathered from glucose monitoring (sensor readings or capillary blood glucose measurements), insulin dosing and meal data during daily routine home care. Following a 5-minute data collection and analysis, the algorithm learns and suggests insulin dose adjustments and behavioral tips for optimization of glucose control. The algorithm is designed as an advisory tool for health care professionals.

Trial Locations (1)

49202

schneider children medical center of Israel, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DreaMed Diabetes

INDUSTRY

lead

Rabin Medical Center

OTHER